MediWound Ltd. - Ordinary Shares (MDWD): Price and Financial Metrics

MediWound Ltd. - Ordinary Shares (MDWD): $1.36

0.01 (+0.74%)

POWR Rating

Component Grades













Add MDWD to Watchlist
Sign Up

Industry: Biotech



in industry


  • Growth is the dimension where MDWD ranks best; there it ranks ahead of 69.02% of US stocks.
  • MDWD's strongest trending metric is Sentiment; it's been moving down over the last 37 days.
  • MDWD ranks lowest in Momentum; there it ranks in the 10th percentile.

MDWD Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for MDWD is 12.3 -- better than 97.36% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -29.79 for MEDIWOUND LTD; that's greater than it is for just 0.96% of US stocks.
  • As for revenue growth, note that MDWD's revenue has grown -18.37% over the past 12 months; that beats the revenue growth of merely 9.64% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to MEDIWOUND LTD are GDDY, PTCT, ACER, ICPT, and VTVT.
  • Visit MDWD's SEC page to see the company's official filings. To visit the company's web site, go to

MDWD Valuation Summary

  • In comparison to the median Healthcare stock, MDWD's price/sales ratio is 38% lower, now standing at 3.1.
  • Over the past 106 months, MDWD's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for MDWD.

Stock Date P/S P/B P/E EV/EBIT
MDWD 2022-12-02 3.1 37.6 -3.8 -3.7
MDWD 2022-12-01 3.1 37.9 -3.8 -3.7
MDWD 2022-11-30 3.2 39.4 -4.0 -3.9
MDWD 2022-11-29 3.1 38.3 -3.9 -3.8
MDWD 2022-11-28 3.2 39.4 -4.0 -3.9
MDWD 2022-11-25 3.3 40.8 -4.1 -4.1

MDWD Growth Metrics

    The 2 year net income to common stockholders growth rate now stands at -316.37%.
  • The 4 year net cashflow from operations growth rate now stands at 150.97%.
  • The 4 year price growth rate now stands at -67.85%.
Over the past 30 months, MDWD's revenue has gone down $15,401,000.

The table below shows MDWD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 20.365 -16.12 -16.302
2022-06-30 20.934 -14.372 -15.448
2022-06-30 20.934 -14.372 -15.448
2022-03-31 22.323 -10.103 -14.289
2021-12-31 23.763 -8.916 -13.551
2021-09-30 24.949 -10.033 -11.123

MDWD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • MDWD has a Quality Grade of D, ranking ahead of 14.08% of graded US stocks.
  • MDWD's asset turnover comes in at 0.824 -- ranking 31st of 681 Pharmaceutical Products stocks.
  • VRTX, CHUC, and AERI are the stocks whose asset turnover ratios are most correlated with MDWD.

The table below shows MDWD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.824 0.392 -1.189
2021-03-31 0.709 0.377 -0.788
2020-12-31 0.627 0.347 -0.555
2020-09-30 0.554 0.307 -0.464
2020-06-30 0.484 0.261 -0.326
2020-06-30 0.484 0.261 -0.326

MDWD Price Target

For more insight on analysts targets of MDWD, see our MDWD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $6.92 Average Broker Recommendation 1.33 (Strong Buy)

MDWD Stock Price Chart Interactive Chart >

Price chart for MDWD

MDWD Price/Volume Stats

Current price $1.36 52-week high $3.38
Prev. close $1.35 52-week low $1.15
Day low $1.31 Volume 90,459
Day high $1.41 Avg. volume 123,077
50-day MA $1.43 Dividend yield N/A
200-day MA $1.77 Market Cap 55.40M

MediWound Ltd. - Ordinary Shares (MDWD) Company Bio

MediWound Ltd. focuses on developing, manufacturing, and commercializing products for the treatment of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and others. The company was founded in 2000 and is based in Yavne, Israel.

MDWD Latest News Stream

Event/Time News Detail
Loading, please wait...

MDWD Latest Social Stream

Loading social stream, please wait...

View Full MDWD Social Stream

Latest MDWD News From Around the Web

Below are the latest news stories about MEDIWOUND LTD that investors may wish to consider to help them evaluate MDWD as an investment opportunity.

MediWound Ltd. (MDWD) can excel with these strategies

A share of MediWound Ltd. (NASDAQ:MDWD) closed at $1.67 per share on Tuesday, up from $1.45 day before. While MediWound Ltd. has overperformed by 15.17%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, MDWD fell by -50.88%, with highs and lows ranging from $3.42 to $1.21, […]

US Post News | November 16, 2022

MediWound Reports Third Quarter 2022 Financial Results and Provides Company Update

$30.5 million in gross proceeds raised; operating cash runway through 2025

GlobeNewswire | November 15, 2022

MediWound Ltd. (MDWD) Q3 2022 Earnings Call Transcript

MediWound Ltd. (NASDAQ:NASDAQ:MDWD) Q3 2022 Earnings Conference Call November 15, 2022, 8:30 am ET Company Participants Monique Kosse - MD, LifeSci Advisors Ofer Gonen - CEO Boaz Gur-Lavie…

Seeking Alpha | November 15, 2022

MediWound GAAP EPS of -$0.13 misses by $0.03, revenue of $5.8M beats by $1.2M

MediWound press release (MDWD): Q3 GAAP EPS of -$0.13 misses by $0.03.Revenue of $5.8M (-8.9% Y/Y) beats by $1.2M.

Seeking Alpha | November 15, 2022

MediWound (MDWD) Reports Q3 Loss, Tops Revenue Estimates

MediWound (MDWD) delivered earnings and revenue surprises of -30% and 24.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | November 15, 2022

Read More 'MDWD' Stories Here

MDWD Price Returns

1-mo 0.74%
3-mo -28.80%
6-mo -25.68%
1-year -45.82%
3-year -52.45%
5-year -70.11%
YTD -42.37%
2021 -36.22%
2020 19.35%
2019 -23.65%
2018 -8.76%
2017 -2.84%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5958 seconds.